HER2 Transmembrane Domain Mutations: Rare New Target for Non-Small Cell Lung Cancer Therapy

被引：14

作者：

Notsuda, Hirotsugu ^{[1
,2
]}

Bradbury, Penelope A. ^{[3
,4
]}

Tsao, Ming-Sound ^{[1
,2
]}

机构：

[1] Univ Toronto, Princess Margaret Canc Ctr, Dept Pathol, Univ Hlth Network, Toronto, ON, Canada

[2] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada

[3] Univ Toronto, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada

[4] Univ Toronto, Dept Med, Toronto, ON, Canada

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 03期

基金：

加拿大健康研究院;

关键词：

KINASE DOMAIN; DRUGS;

D O I：

10.1016/j.jtho.2017.01.007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：422 / 424

页数：3

共 12 条

[1] Molecular profiling of metastatic breast cancer in body cavity fluids [J].

Ashfaq, R. ;

Fong, E. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)

[2] MULTIPLE INDEPENDENT ACTIVATIONS OF THE NEU ONCOGENE BY A POINT MUTATION ALTERING THE TRANSMEMBRANE DOMAIN OF P185 [J].

BARGMANN, CI ;

HUNG, MC ;

WEINBERG, RA .

CELL, 1986, 45 (05) :649-657

[3] Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT) [J].

Barlesi, Fabrice ;

Mazieres, Julien ;

Merlio, Jean-Philippe ;

Debieuvre, Didier ;

Mosser, Jean ;

Lena, Herve ;

Ouafik, L'Houcine ;

Besse, Benjamin ;

Rouquette, Isabelle ;

Westeel, Virginie ;

Escande, Fabienne ;

Monnet, Isabelle ;

Lemoine, Antoinette ;

Veillon, Remi ;

Blons, Helene ;

Audigier-Valette, Clarisse ;

Bringuier, Pierre-Paul ;

Lamy, Regine ;

Beau-Faller, Michele ;

Pujol, Jean-Louis ;

Sabourin, Jean-Christophe ;

Penault-Llorca, Frederique ;

Denis, Marc G. ;

Lantuejoul, Sylvie ;

Morin, Franck ;

Quan Tran ;

Missy, Pascale ;

Langlais, Alexandra ;

Milleron, Bernard ;

Cadranel, Jacques ;

Soria, Jean-Charles ;

Zalcman, Gerard .

LANCET, 2016, 387 (10026) :1415-1426

[4] Targeted therapy for non-small cell lung cancer: current standards and the promise of the future [J].

Chan, Bryan A. ;

Hughes, Brett G. M. .

TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (01) :36-54

[5] Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu [J].

De Greve, J. ;

Teugels, E. ;

Geers, C. ;

Decoster, L. ;

Galdermans, D. ;

De Mey, J. ;

Everaert, H. ;

Umelo, I. ;

In't Veld, P. ;

Schallier, D. .

LUNG CANCER, 2012, 76 (01) :123-127

[6] Outcomes of chemotherapies and HER2 directed therapies in advanced HER2-mutant lung cancers [J].

Eng, Juliana ;

Hsu, Meier ;

Chaft, Jamie E. ;

Kris, Mark G. ;

Arcila, Maria E. ;

Li, Bob T. .

LUNG CANCER, 2016, 99 :53-56

[7] Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs [J].

Kris, Mark G. ;

Johnson, Bruce E. ;

Berry, Lynne D. ;

Kwiatkowski, David J. ;

Iafrate, A. John ;

Wistuba, Ignacio I. ;

Varella-Garcia, Marileila ;

Franklin, Wilbur A. ;

Aronson, Samuel L. ;

Su, Pei-Fang ;

Shyr, Yu ;

Camidge, D. Ross ;

Sequist, Lecia V. ;

Glisson, Bonnie S. ;

Khuri, Fadlo R. ;

Garon, Edward B. ;

Pao, William ;

Rudin, Charles ;

Schiller, Joan ;

Haura, Eric B. ;

Socinski, Mark ;

Shirai, Keisuke ;

Chen, Heidi ;

Giaccone, Giuseppe ;

Ladanyi, Marc ;

Kugler, Kelly ;

Minna, John D. ;

Bunn, Paul A. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (19) :1998-2006

[8] Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort [J].

Mazieres, J. ;

Barlesi, F. ;

Filleron, T. ;

Besse, B. ;

Monnet, I. ;

Beau-Faller, M. ;

Peters, S. ;

Dansin, E. ;

Frueh, M. ;

Pless, M. ;

Rosell, R. ;

Wislez, M. ;

Fournel, P. ;

Westeel, V. ;

Cappuzzo, F. ;

Cortot, A. ;

Moro-Sibilot, D. ;

Milia, J. ;

Gautschi, O. .

ANNALS OF ONCOLOGY, 2016, 27 (02) :281-286

[9] Lung Cancer That Harbors an HER2 Mutation: Epidemiologic Characteristics and Therapeutic Perspectives [J].

Mazieres, Julien ;

Peters, Solange ;

Lepage, Benoit ;

Cortot, Alexis B. ;

Barlesi, Fabrice ;

Beau-Faller, Michele ;

Besse, Benjamin ;

Blons, Helene ;

Mansuet-Lupo, Audrey ;

Urban, Thierry ;

Moro-Sibilot, Denis ;

Dansin, Eric ;

Chouaid, Christos ;

Wislez, Marie ;

Diebold, Joachim ;

Felip, Enriqueta ;

Rouquette, Isabelle ;

Milia, Julie D. ;

Gautschi, Oliver .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (16) :1997-U307

[10] HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodirnerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to Afatinib [J].

Ou, Sai-Hong Ignatius ;

Schrock, Alexa B. ;

Bocharov, Eduard V. ;

Klempner, Samuel J. ;

Haddad, Carolina Kawamura ;

Steinecker, Gary ;

Johnson, Melissa ;

Gitlitz, Barbara J. ;

Chung, Jon ;

Campregher, Paulo V. ;

Ross, Jeffrey S. ;

Stephens, Philip J. ;

Miller, Vincent A. ;

Suh, James H. ;

Ali, Siraj M. ;

Velcheti, Vamsidhar .

JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (03) :446-457

← 1 2 →